Just In
- 13 min ago Parineeti Chopra Saree Looks: Check Amar Singh Chamkila Actor's Regal Fashion Statements
- 2 hrs ago Vidya Balan's 'Do Aur Do Pyaar' Urban Boho Style Avatar Is Relatable And Inspiring, Check Her Modern Avatar!
- 10 hrs ago Golden Rules To Follow For Happy Marriage For A Long Lasting Relationship
- 10 hrs ago Gajalakshmi Rajyog In Aries 2024: Lucky Zodiac Signs Who Will Get Financial Benefits
Don't Miss
- Movies Paarijatha Parvam Full Movie Leaked Online In HD For Free Download Hours After Its Theatrical Release
- Technology itel S24 With 108MP AI Dual Camera India Launch Confirmed; Amazon Microsite Goes Live
- Finance Daily Relative Strength Index RSI In A Bullish Mode of This Pharma Stock; Buy For TP Rs 635-685
- News Indonesian Volcano Spews Clouds Of Ash, Authorities Evacuate Over 2,100 People
- Sports RCB Green Jersey Match: Record And Stats Ahead of KKR Meeting in IPL 2024
- Automobiles Mahindra XUV 3XO SUV – Everything We Know So Far
- Education Exam Pressure Does Not Exist; Studying Punctually is Crucial; Says Aditi, the PSEB 2024 Topper
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
BA.2.38 Has Not Led To Any Increase In Hospitalisation, Disease Severity: INSACOG Reports
Omicron sub-variant BA.2's offspring BA.2.38 has not led to any increase in hospitalisation or disease severity, and a few deaths reported recently are due to comorbidities, Insacog said in its June 20 bulletin released on Sunday.
In the bulletin, the Indian SARS-CoV-2 Genomics Consortium (Insacog) said many BA.2 cases have been reclassified to BA.2.38 and it seems to be the prevalent sub-lineage in the latest sequencing batches, it said.
"However, so far, this has not led to any increase in hospitalisation or any report of an increase in disease severity. A few deaths that have been reported recently are due to comorbidities. COVID-appropriate behavior is likely to reduce the spread of the infection and hence continues to be recommended," it said.
In its previous bulletin dated June 13, which was also released on Sunday, the Insacog said BA.2 continues to be the dominant lineage in India.
"However, hospitalisation due to the severity of the disease has not been observed that much. INSACOG is closely monitoring the current situation," it said.
In another bulletin dated May 30, the Insacog informed us that till then, five cases of BA.4 and three cases of BA.5 had been reported in India.
The Insacog reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India.
- healthXBB.1.16: Symptoms; Are Vaccines Useful? WHO Concerned Over Recent COVID Spike In India
- disorders cureCommon COVID Symptoms In Fully Vaccinated Individuals: What You Should Know
- wellnessMild COVID Linked To Life-Threatening Blood Clots, Increased Risk Of Cardiovascular Disease; Study
- wellnessCOVID-19 Variants In India: New COVID Variant May Pose Threat To Elderly People
- basicsCovid-19 Linked To Early Onset Of Periods: What You Need To Know
- wellnessCOVID XBB Variants Of Omicron In India: What You Should Know
- disorders cureNew Omicron Subvariant BQ.1 Detected In Maharashtra: What You Should Know
- disorders cureOmicron BF.7 In India, Risk Of Fresh Wave During Diwali: What You Should Know
- wellnessOld Age Is A Risk Factor For Pneumonia Due To The Omicron Variant: Study
- disorders cureWhat Is ‘Centaurus,’ New Fast-Spreading Covid Variant: Everything You Need To Know
- health75 Years Of Independence, 75 Days Of Free COVID Booster Shots; For Everyone Aged 18-59 From 15 July
- wellnessWhat Are The Health Risks Of Getting COVID The Second Or Third Time? 7 Important Points